Market Place
Sourcing Support
Novartis` $12B Avidity Buy Pays Off with Phase 1/2 MD Win
13 Jun 2026 //
BIOSPACE
Novartis Says Rare Muscle Disease Drug Shows Promise in Trial
13 Jun 2026 //
REUTERS
Novartis RemIND Data Show Rhapsido Potential for CIndU
12 Jun 2026 //
GLOBENEWSWIRE
Novartis sticks 2nd deal with Orionis, this one worth up to $1.4B
11 Jun 2026 //
FIERCE BIOTECH
Genentech and Novartis dish up food allergy microdrama series
10 Jun 2026 //
FIERCE PHARMA
Novartis to Show Rhapsido Data Across Diseases at EAACI 2026
08 Jun 2026 //
GLOBENEWSWIRE
Novartis IgAN Data in Lancet Show Kidney Decline Slow by Vanrafia
04 Jun 2026 //
GLOBENEWSWIRE
Novartis Cosentyx Sustain Remission in Twice as Many PMR Patients
03 Jun 2026 //
GLOBENEWSWIRE
Novartis Showcases Strong Immunology Portfolio Momentum At EULAR
01 Jun 2026 //
GLOBENEWSWIRE
Scemblix Maintains Superior Efficacy In Newly Diagnosed CML
01 Jun 2026 //
GLOBENEWSWIRE
Pluvicto Shows Consistent Efficacy in mHSPC Patient Subgroups
31 May 2026 //
PRESS RELEASE
Novartis Actinium-Based Drug Shows Promise in Prostate Cancer
31 May 2026 //
ECONOMICTIMES
Novartis Kidney Disease Data Reinforces Portfolio at ERA 2026
26 May 2026 //
GLOBENEWSWIRE
Regenxbio, Novartis & Dyne Near FDA Filing for Muscular Dystrophy
26 May 2026 //
BIOSPACE
Has Novartis` T-Charge Been Overtaken by In Vivo CAR-Ts?
22 May 2026 //
FIERCE BIOTECH
Abbvie, Novartis Slash US Headcount
22 May 2026 //
BIOSPACE
Novartis Presents RLT and Oncology Data at ASCO and EHA 2026
21 May 2026 //
GLOBENEWSWIRE
PhRMA, Novartis Weigh In On FDA`s 3-Year Exclusivity Guidance
18 May 2026 //
RAPS
Psmaddition Data Reveals 58% Lower PSA Progression Risk
17 May 2026 //
GLOBENEWSWIRE
Novartis Sharpening India Strategy As A Pure-Play Innovator
14 May 2026 //
ECONOMICTIMES
Novartis expands India role in global drug development
11 May 2026 //
ECONOMICTIMES
Novartis to Exit Oral Drug Factory in Germany
08 May 2026 //
FIERCE PHARMA
Novartis Breaks Ground on Texas Radioligand Therapy Site
07 May 2026 //
GLOBENEWSWIRE
Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3
05 May 2026 //
FIERCE BIOTECH
Novartis Gets Health Canada Nod For Fabhalta In Adult C3G
02 May 2026 //
FIRSTWORD PHARMA
Novartis Reveals North Carolina Factory In $23B US Expansion
30 Apr 2026 //
ENDPOINTS
Lilly Inks Deals; Regeneron Secures Historic Q1 Win
29 Apr 2026 //
BIOSPACE
Novartis, PTC Advance Huntington`s Drug to Phase 3
29 Apr 2026 //
BIOSPACE
PTC Therapeutics To Share PIVOT-HD Study Long-Term Results
28 Apr 2026 //
PR NEWSWIRE
Novartis Posts Strong Q1 Growth, Reaffirms 2026 Guidance
28 Apr 2026 //
GLOBENEWSWIRE
Novartis CEO Concerned About Germany`s €60B Healthcare Spending
28 Apr 2026 //
ENDPOINTS
Argo Biopharma Doses First Patient in BW-50218 Phase 1 Trial
28 Apr 2026 //
PR NEWSWIRE
Novartis Cuts Hit New Jersey Again, Affecting 60 Employees
28 Apr 2026 //
BIOSPACE
Novartis Reports Earnings Miss Due To Generic Competition
28 Apr 2026 //
REUTERS
Novartis Highlights First Quarter Earnings Call
28 Apr 2026 //
FIRSTWORD PHARMA
EU Approves Novartis` Rhapsido as First Oral Therapy for CSU
27 Apr 2026 //
GLOBENEWSWIRE
Novartis` Coartem Baby Granted WHO Prequalification
24 Apr 2026 //
GLOBENEWSWIRE
Novartis Gets CHMP Nod For Itvisma In SMA
24 Apr 2026 //
GLOBENEWSWIRE
Novartis’s Rhapsido Receives Approval in Europe
23 Apr 2026 //
EMA
NCCN Honors Initiatives Advancing Leukemia CML Care
23 Apr 2026 //
PR NEWSWIRE
Novartis` Lutathera Radioligand Therapy Faces Generic Rivals
23 Apr 2026 //
ENDPOINTS
Novartis Narrows Anticoagulant`s Focus After Losing To Eliquis
22 Apr 2026 //
FIERCE BIOTECH
Novartis cuts two Programs in Cancer-Related Blood Clots
20 Apr 2026 //
ENDPOINTS
Novartis CEO Vas Narasimhan joins Anthropic board
20 Apr 2026 //
INDPHARMAPOST
NIPER Mohali And Novartis Partner To Enhance R&D Innovation
16 Apr 2026 //
INDPHARMAPOST
Novartis CEO Vas Narasimhan joins Anthropic`s board
16 Apr 2026 //
FIERCE PHARMA
Novartis Pumps Up Heart Disease, Cancer Community Health Plan
10 Apr 2026 //
FIERCE PHARMA
Novartis To Cut 114 More Jobs At New Jersey HQ
10 Apr 2026 //
FIERCE PHARMA
Novartis Expands Global Health Programs For Heart Disease
09 Apr 2026 //
GLOBENEWSWIRE
Biontech To Turn Out The Lights At Singapore Vaccine Facility
02 Apr 2026 //
FIERCE PHARMA
BMS, Novartis, Gilead, Iovance Dinged In CBER Untitled Letters
30 Mar 2026 //
FIERCE PHARMA
Novartis Data In Nejm: Fabhalta Slows Kidney Decline By 49.3%
29 Mar 2026 //
GLOBENEWSWIRE
Novartis to buy based biotech firm Excellergy for up to $2 bn
27 Mar 2026 //
REUTERS
Novartis Sued Over Third-Party Data Sharing From Branded Sites
25 Mar 2026 //
FIERCE PHARMA
Novartis Pledges $480M for China Expansion Following Lilly and AZ
24 Mar 2026 //
BIOSPACE
Novartis Shares Skin Relief Data at AAD 2026
23 Mar 2026 //
GLOBENEWSWIRE
Novartis Pledges Nearly $480M To Bolster China Production, R&D
23 Mar 2026 //
WEIXIN
Novartis to Buy Experimental Breast Cancer Drug in up to $3B
23 Mar 2026 //
REUTERS
Delhi HC Rebukes Patent Office For Delay In Breast Cancer Drug
18 Mar 2026 //
ECONOMICTIMES
Novartis` Cosentyx Gets FDA Approval for Moderate-to-Severe HS
14 Mar 2026 //
GLOBENEWSWIRE
